Svmuu Svmuu reports that Moderna, the American pharmaceutical giant, has announced it has begun developing a hantavirus vaccine, with the work currently in its early stages. The statement said Moderna has partnered with the U.S. Army Medical Research Institute of Infectious Diseases to conduct early research on a hantavirus vaccine.
Additionally, Moderna has been collaborating with the Vaccine Innovation Center at Korea University College of Medicine to develop potential immunization regimens. This research began before the outbreak on the "Hondius" ship. Moderna stated: "These efforts are still in their early stages and are ongoing." (Golden Ten)
Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Moderna: Developing Hantavirus Vaccine
Recommended Reading




